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Abstract
Islet-infiltrating lymphocytes of individual male and female non-obese diabetic (NOD) mice were
examined with the purpose of determining the differences that lead to a predominance of diabetes in
female versus males NOD mice. When normalized for the amount of islet lymphocytes recovered,
the infiltrating lymphocytes of female NOD mice were indistinguishable from those of male NOD
mice. The only observed difference was that islet inflammation progressed at an increased rate in
female compared to male NOD mice. There was no difference in the composition of islet infiltrates
in male and female NOD mice. Unexpectedly, the ratio of CD4+:CD8+ T cells was tightly controlled
in the islets throughout diabetogenesis. The frequency of IL-4+ CD4+ T cells started high but quickly
fell to 3% of the population which was maintained with increasing inflammation. A significant
portion of the CD8+ T cells were islet-specific glucose-6-phosphatase catalytic subunit-related
protein (IGRP) specific in both male and female NOD mice and this population was antigen
experienced and increased at high levels of islet inflammation. Surprisingly, a large pool of antigen
inexperienced naïve T cells was detected in the islets. We conclude the underlying immunological
processes in both male and female NOD mice are similar while the rates differ and the presence of
naïve T cell in the islets may contribute to epitope spreading.
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INTRODUCTION
Type I diabetes (T1D) is caused by the immune destruction of the insulin-producing pancreatic
β cells. Based on studies with the non-obese diabetic (NOD) mouse, the primary mediators of
β cell destruction are CD4+ and CD8+ T cells 1–3. NOD mice spontaneously develop T1D,
with 80% of females and 20% of males becoming overtly diabetic by 20 weeks of age4. The
immunological basis for the disparity between the sexes, however, is not well characterized
5,6. Sex hormones influence the time of onset of T1D. Disease incidence is increased in
castrated NOD males and administration of testosterone delays the onset of disease in NOD
females7–10. In addition, several studies have examined the Th1/Th2 cytokine balance in male
and female NOD mice and found that T cells were skewed to produce more Th1 cytokines in
young females than in young males, although islet infiltrating cells from both male and female
NOD mice can produce diabetes in NOD scid mice 11–13. Presently, the effect of the sex
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hormones on the immune system remains poorly understood and the balance of lymphocyte
subsets in the islets in NOD males versus females over time has not been studied.
Susceptibility to diabetes is genetically linked in both NOD mice and humans to the MHC
class II alleles. NOD mice deficient in β2-microglobulin and CD8+ T cells fail to develop
diabetes. Thus, both CD4+ and CD8+ T cells are important for development of diabetes in NOD
mice 14–25. Given the importance of T cells in T1D, there have been many attempts to
understand their role in the progression of β cell autoimmunity 26,27. Unfortunately, these
efforts have been hampered by the paucity of T cells that can be recovered from the islets. As
a result, many studies have used pooled islets from several NOD mice, pancreatic lymph nodes
(PLN), or spleen cells to study the progression and nature of the autoimmune response 12,28–
31. While these studies have aided in elucidating the systemic immune response, a critical
analysis of the T cell response in the islets from single individuals is still lacking.
Using multi-color flow cytometry we directly analyzed the islet-infiltrating lymphocytes of
individual male and female NOD mice, then considered the data both as individual mice and
in groups. Islets of female NOD mice were more heavily infiltrated than the islets of age
matched males. Surprisingly, when considered as individuals and matched by the level of
lymphocyte infiltration instead of age, the composition of islet infiltrates of male NOD mice
resembles that of females. The number of both IL-4+ CD4+ T cells and Treg increased over
time in the islets. In spite of this increase, the percentage of IL-4+ CD4+ T cells decreased.
Interestingly in the midst of these changes, the ratio of CD4+:CD8+ T cells in the islets remained
constant. Male NOD mice had antigen experienced IGRP reactive CD8+ T cells in their islets.
These data indicate that male and female NOD mice progress towards diabetes with the same
balance of lymphocytes, but at very different rates. A surprising finding of this study was the




NOD/ShiLtJ mice and C.129-Il4tml Lky/J mice were purchased from Jackson Laboratories32.
In our facility, female NOD mice become diabetic at a median age of 16 weeks, with 75%
diabetic by 20 weeks of age indistinguishable from NOD/ShiLtJ mice at Jackson Labs(see
Supplemental Fig. 1). In order to examine T cells with a Th2 phenotype, NOD IL-4 reporter
mice (NOD.Cg-Il4tml Lky/Fre) were created by backcrossing the reporter gene from C.129-
Il4tml Lky/J mice onto the NOD background using speed congenics 32,33. These NOD mice
express eGFP when IL-4 mRNA is produced. Forty-three SNPs (Supplemental data Table 1)
were used to distinguish between the BALB/c and NOD genomes. The IL-4 gene, located on
chromosome 11 at base pair position 53 million, was flanked by SNPs at positions 33 million
and 77 million; both were homozygous for NOD DNA. By backcross (BC)4 (N5), 41 of the
42 SNPs were homozygous for NOD markers (98.8% of the SNPs) and female mice in the N4
or BC3 generation became diabetic. The mice were backcrossed 3 more times without SNP
selection to BC6 to assure homogeneity of the NOD genetic background. To select newly
diabetic mice, blood sugar was monitored weekly using a FreeStyle Blood Glucose Meter and
mice were considered diabetic after 2 consecutive blood glucose readings of over 250 mg/dL.
Only mice with a blood sugar <150 mg/dL were used in this study, unless specifically
designated as a diabetic mouse.
Isolation of Lymphocytes from Islets
Pancreata were isolated as previously described 34. Briefly, each pancreas was perfused with
a 2 mg/ml solution of Collagenase P (Sigma), dissected and incubated at 37°C for 20 minutes.
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Islets were purified using a Ficoll PM 400 (Sigma) gradient, handpicked, counted and then
cultured overnight in RPMI 1640 media containing 10% FBS and 4 ng/ml recombinant murine
IL-2 (Invitrogen). Infiltrating lymphocytes were collected and filtered through a 40μm nylon
filter. All islet-infiltrating cells from every mouse were analyzed by flow cytometry. Because
the number of islets recovered is not uniform among mice, the “number of cells per islet” was
determined by dividing the total number of cells in the sample by the number of cultured islets;
therefore, a mouse that had 100 CD8+ T cells, 400 CD4+ T cells and 300 B cells recovered
from 100 islets would be recorded as having 1 CD8+ T cell, 4 CD4+ T cells and 3 B cells per
islet. Each sample constitutes all of the islet cells isolated from an individual mouse. An average
of 103 islets was isolated per mouse. For further examples of how data was collected and
treated, a chart of the raw data presented in Fig. 3 is included (Supplemental data Table 2). The
data from each individual mouse was analyzed individually or alternatively combined with the
data from mice of like sex and age to examine inter group differences.
Flow Cytometry
Splenocytes and lymphocytes from NOD mice were examined using 9 color flow cytometry.
Cells were stained with a cocktail of APC-Cy7-anti-CD3 (BD Biosciences, San Jose, CA),
Pacific Orange-anti-CD4 (Invitrogen, Carlsbad, CA), PerCP-anti-CD8 (BD), Pacific Blue-
anti-CD44 (Invitrogen), APC-anti-CD25 (eBioscience), PE-Texas Red-anti-CD62
(Invitrogen), PE-Cy7-anti-CD19 (BioLegends, San Diego, CA) and PE-ultra-avidin (Lenco,
St. Louis, MO)-NRP-V7-Kd tetramer. Antibody concentrations used were determined by
preliminary titrations. To assess FoxP3 expression, cells were fixed, permeablized and stained
with PE-anti-FoxP3 antibody (eBioscience). Cells were analyzed on a Dako (Beckman-
Coulter) Cyan-ADP(Colorado Springs, CO). “Minus one” controls were performed in each
experiment to ensure that the fluorescence measured originated from the correct stain. Staining
controls used syngeneic spleen cells.
Tetramer
H2Kd tetramers were prepared as previously described 35. Briefly, H2Kd, modified to contain
a biotinylation sequence, and mouse β2 microglobulin were produced in E. coli and refolded
with NRP-V7 peptide (KYNKANVFL from GenScript) in vitro, an islet-specific glucose-6-
phosphatase catalytic subunit-related protein (IGRP) mimotope 36. Refolded NRP-V7-H2Kd
monomer was purified by HPLC, biotinylated using Biotin Protein Ligase and assembled into
tetramers by conjugation with UltraAvidin-R-PE (Leinco). In NOD mice most of the IGRP+
CD8+ T cells are also NRP-V7+. For convenience, NRP-V7 reactive cells are referred to as
IGRP-specific.
RESULTS
Female NOD mice have more islet-infiltrating T cells than males at the same age
We examined the number of T cells infiltrating the islets. In both NOD males and females, the
number of CD4+, CD8+ and B cells increased with age. In NOD males, there was an ~two-
fold increase in the number of infiltrating cells, whereas a five-fold increase of CD4+, CD8+
and B cells was detected in NOD female mice between 6–8 and 12–14 weeks of age (Fig. 1A).
This is consistent with previous reports that islets of NOD female mice are more heavily
infiltrated than NOD male mice of the same age 5. However, it is of note that the number of
infiltrating cells in males also increased with age, albeit more slowly than in females. 25–29
week-old male NOD mice were examined to determine if β cell autoimmunity continued to
increase in males and levels of insulitis comparable to those seen in the 12–14 week-old females
was achieved, or if insulitis in males was arrested at a certain point and did not progress. We
found that 25–29 week-old male NOD mice had levels of islet lymphocytes similar to 12–14
week-old female NOD mice. By 25–29 weeks nearly all female NOD mice became overtly
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diabetic (Supplemental Fig. 1). We considered diabetic mice separately regardless of age and
no diabetic mice were included in the analysis unless explicitly noted.
The composition of islet-infiltrating lymphocytes is similar in female and male NOD mice
We determined the composition of infiltrating cells over time in spleen, peripheral and PLN
and the islets of NOD mice. Surprisingly, when grouped into 6–8 week and 12–14 week-old,
males and females, there was no significant change in the percentage of CD4+, CD8+ or B cells
over time in the spleen, peripheral lymph nodes, PLN or islets (Fig. 1B). Thus, while the number
of infiltrating cells increased, the overall composition did not change.
Examination of individual NOD mice indicates CD4+ to CD8+ T cell ratios are tightly controlled
in the islets
When individual NOD mice were examined, regardless of their sex or age, a linear relationship
between the number of CD4+ and CD8+ T cells per islet was detected, indicating a strong
association between the number of CD4+ and CD8+ T cells that is maintained in the islets
during the progression of β cell autoimmunity in both males and females (Fig. 1C) (r2= 0.9735).
The number of B cells also increased linearly with CD4+ T cells (r2 of 0.7212); however, the
ratio of B cells to CD4+ T cells was less tightly regulated compared to CD8+ T cells (Fig. 1C
and D).
To further investigate the ratios of lymphocyte subsets as β cell autoimmunity progressed, we
examined diabetic female NOD mice and 25–29 week-old male NOD mice. Diabetes is the
consequence of β cell autoimmunity; however, loss of blood glucose homeostasis could alter
the control mechanism. Therefore, islets were isolated from female NOD mice within 10 days
of a blood glucose level >250 mg/dL. These mice had a CD4+:CD8+ T cell ratio of 2.7+/−
0.52, similar to non-diabetic female NOD mice (Fig 2). We then examined 25–29 week-old
non-diabetic male NOD mice and found a statistically equivalent CD4+:CD8+ T cell ratio of
3.5+/− 0.77; again indistinguishable from younger non-diabetic females (Fig 2). Therefore at
the onset of diabetes and in very old male NOD mice the number of infiltrating cells had greatly
increased but the CD4+:CD8+ T cell and B cell:T cell ratios remained the same.
A small but significant number of Th2 cells are detected in the islets of NOD mice
Th2 cell responses have been suggested to regulate at least some Th1 and Tc1 cell responses
37,38. We examined the expression of IL-4 secreting CD4+ T cells using NOD IL-4 reporter
mice 32,39. The percentage of IL-4 producing CD4+ T cells was much higher in the islets of
males and young females than in the spleen, peripheral lymph nodes and PLNs (Fig. 3A). The
level of IL-4 producing CD4+ T cells in the spleen and periphery was the same in all mice
regardless of sex and age. In contrast the percentage of IL-4 producing CD4+ T cells in the
islets decreased with age in both males and females. When individual mice were examined, it
became obvious that mice with low levels of infiltrates had higher levels of IL-4 producing
CD4+ T cells (Fig. 3B & C). The percentage of IL-4 producing CD4+ T cells decreased before
the number of CD4+ T cells reached 25 per islet, then maintained a constant level, consisting
of ~3% of the CD4+ T cell population. Surprisingly when the number of IL-4 producing
CD4+ T cells was directly compared to the total CD4+ T cells per islet, the number of IL-4
producing CD4+ T cells increased linearly with the increase of CD4+ T cell per islet, r2=0.94.
The best fit line had a slope of 0.03 indicating an overall composition of 3% IL-4 competent
cells in the CD4+ T cell population (Fig. 3D). At very low numbers of infiltrating CD4+ T
cells, those cells are highly IL-4 producing. This was suggested because the best fit line does
not pass through zero (see Supplemental Fig. 3). Close inspection of the raw data confirms that
when very few cells (<50 CD4+ T cells/mouse) were recovered from the islets, they are 34%
IL-4 competent. Overall our data demonstrates that the first CD4+ T cells to reach the islets
had an increased percentage of IL-4 competent cells and while the IL-4 producing CD4+ T
Young et al. Page 4













cells increased, they initially did so more slowly than the non-IL-4 producing CD4+ T cells
and so were not able to influence the diabetegenic cells effectively.
Islet Tregs increase more slowly than effector T cells
FoxP3+ Tregs are important in regulating autoimmunity. Strikingly, the frequency of
FoxP3+ CD4+ T cells in the spleen, peripheral lymph nodes and PLNs was similar and stable
at ~7–12% at all times examined. The highest level of Treg was in the islets where the frequency
of Treg increased in NOD males between 6 and 12 weeks of age. The percentage decreased in
NOD females, despite an increased number of FoxP3+ CD4+ T cells per islet over this same
time (Fig. 4A, B and C). Thus, the drop in frequency in females was due to dilution in a greater
number of FoxP3− CD4+ T cells. In individual NOD mice, the percentage of FoxP3+ CD4+ T
cells was high in the early stages of β cell autoimmunity, with the exception of a few mice that
had very few cells in the islets, but gradually decreased after 50 CD4+ T cells per islet (Fig.
4D). When the analysis was repeated using the CD25hi population as a surrogate marker for
Treg, similar results were obtained (Fig. 4C). In 12–14 week-old male NOD mice, 20 percent
of the islet-infiltrating CD4+ T cells were CD25hi, compared to only 13–15% were CD25hi in
the islets of 25–29 week-old NOD male mice, indicating that Treg also decreased in males but
at an older age. This suggests that Treg might be effective in young NOD females and older
NOD males.
Antigen experienced IGRP-specific CD8+ T cells are found in the islets of both male and
female NOD mice
IGRP is a known target of diabetogenic CD8+ T cells. A striking increase in the number, but
not the percentage of IGRP-specific CD8+ T cells was detected in the islets (Fig. 5). The number
of IGRP-specific CD8+ T cells in the islets of older NOD females increases 10-fold compared
to age matched males (Mann Whitney test p= 0.004) (Fig. 5B). Nevertheless, 25–29 week-old
male NOD mice had levels of IGRP-specific CD8+ T cells comparable to the 12–14 week-old
females. Also the percentage of CD8+ T cells that were IGRP-specific was similar in NOD
males and females (Fig. 5C). In contrast to the phenotype of IGRP-specific CD8+ T cells found
in the periphery, nearly all of the IGRP-specific CD8+ T cells in the islets were effector
phenotype, CD62Llo and CD44hi (Fig. 5A). In the periphery there was a significant fraction
of naïve, CD62Lhi and CD44lo, or memory cells, CD62Lhi and CD44hi, but relatively few
IGRP-specific CD8+ T cells with an effector phenotype (Fig. 5D). Thus the IGRP-specific
CD8+ T cells in the islets of both male and female NOD mice are antigen experienced. This is
consistent with previous research demonstrating islet-infiltrating lymphocytes can transfer
diabetes to NOD scid recipients 11.
IGRP-specific CD8+ T cells represent a dominant specificity
We examined the relationship of CD8+ T cell number to the number of IGRP-specific CD8+
T cells. Interestingly, when the islets reached a critical level of inflammation (as defined by
the number of CD8+ T cells/the number of islets from individual mice), the number of IGRP-
specific CD8+ T cells increased faster than the total number of CD8+ T cells infiltrating the
islets of NOD mice (Fig. 6A). The change in rate suggests that the total number of T cells
increased at a constant rate, but IGRP reactive CD8+ T cells increased more rapidly in the
islets. Indeed, this is consistent with expansion in situ the IGRP-specific CD8+ T cells made
up a major subset of the effector CD8+ T cells in the young animals (Fig. 6B).
With increasing insulitis an increasing portion of the islet infiltrating T cells are naïve
While nearly all of the IGRP-specific CD8+ T cells in the islets were CD44hi and CD62Llo
indicating they were antigen experienced and effector cells, a large portion of the CD8+ T cell
pool in the islets was CD44lo and CD62Lhi indicating they are not antigen experienced and
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appear to have a naïve phenotype (Fig. 7A). The percent of CD44lo, CD62Lhi CD8+ T cells
increased with age in both male and female NOD mice (Fig. 7B). An equivalent population
was also observed in the CD4+ T cell pool; however, a smaller portion of the CD4+ T cell pool
had a naïve phenotype in the islets (Fig. 7C). When individual mice were compared, naïve T
cells increased with increasing insulitis (Fig. 8).
We re-examined IL-4 competent T cells in the islets and found they were all CD44hi and
CD62Llo, thus effector cells (data not shown). FoxP3+ CD4+ T cells were all CD44hi with
some CD62Llo cells and some CD62Lhi cells, thus effector and memory cells (data not shown).
Thus, the naïve phenotype cells in the islets were unlikely to be anti-islet CD8+ T cells, Th2
cells or Treg cells. This demonstrates an influx of peripheral naïve T cells.
Naïve T cells are not detected until the number of CD4+ T cells reaches 6.4 CD4+ T cells per
islet indicating a threshold for inflammation is needed before naïve cells can enter (Fig. 8). A
similar, but less pronounced, effect is seen for CD8+ T cells.
DISCUSSION
It has been documented that females have a higher incidence of autoimmune diseases both in
humans and mice 40,41. NOD females are known to have a higher burden of islet infiltrates
than males of the same age, correlating with an earlier onset of overt diabetes 4. The
composition of islet-infiltrating lymphocytes in individual males and females has not
previously been compared. We compared age-matched groups of male and female NOD mice
and because of the disparity of islet inflammation between these two groups, we also compared
the mice individually, based on their level of islet inflammation.
We found a surprisingly large percentage of B cells in the islets of both male and female NOD
mice. This has been previously reported in female NOD mice but not in males 29,42. We report
here that a large pool of B cells was present in the islets even as female NOD mice became
diabetic and the tight relationship between the CD8+ and CD4+ T cells in the islets was
maintained.
Despite the disparity in the level of inflammation, NOD males were similar to females in the
tight control of the CD4+:CD8+ ratio and the CD4+ T cell:B cell ratio in the islets. Very old
males attained levels of islet infiltrates similar to or greater than those seen in 12 week-old
NOD females and with strictly controlled CD4+:CD8+ T cell ratios. This observation indicates
that inflammation develops more slowly in males but in a similar manner. Indeed, in many
NOD colonies the males can develop a significant incidence of diabetes43.
Progression of β cell autoimmunity with a fixed ratio of CD4+ and CD8+ T cells is puzzling.
One possibility is that T cells in the islets are in equilibrium with the rest of the immune system,
but this goes against the idea that entry into the islets is only accomplished by T cells that are
activated in the PLN. That theory would require the lymph node to activate the appropriate
ratios of CD4+ and CD8+ T cells. The tertiary lymphoid structure hypothesis posits that
structures form in the islets that are similar to lymph nodes and in equilibrium with the rest of
the body. If this is the case, a stringently controlled CD4+:CD8+ T cell ratio would be expected.
However, a tightly controlled T cell:B cell ratio would also be expected and twice the level of
B cells was found in the islets compared to the lymph nodes (Fig. 1B and D).
It has been shown that induction of IL-4+ CD4+ T cells can significantly delay the onset of
diabetes and constitutive expression of IL-4 in the islet cells abrogates insulitis 37,38.
Paradoxically, IL-4 knockout NOD mice have a normal onset of diabetes 44. We found that
male NOD mice as a group had higher percentages of IL-4 competent CD4+ T cells in their
islet-infiltrating CD4+ T cell pool than their female counterparts. However, when examined as
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a continuum of increasing inflammation, it was obvious that mice with very low levels of islet
inflammation had high percentages of IL-4 competent cells in their infiltrating CD4+ T cell
pool regardless of sex. In both male and female NOD mice, the contribution of IL-4+ expressing
cells to the CD4+ T cell pool was considerably reduced early as diabetogenesis progressed,
indicating that the differences were a result of the level of inflammation and not a characteristic
of male or female. Bao et al. previously observed that, when stimulated in vitro, islet-infiltrating
CD4+ T cells from 4 week-old male NOD mice produced more IL-4 than those from 4 week-
old female NOD mice 10. Our results support this result, since low levels of inflammation were
seen in very young male NOD mice, so the percentage of CD4+ T cells competent to express
IL-4 can be quite high. The same study found that by 10 weeks the islet-infiltrating CD4+ T
cells of male and female NOD mice produced equivalent amounts of IL-4 when stimulated in
culture. Here we show that as the infiltrate in the islets increases, the percent of IL-4 competent
T cells in the islets falls to 3% of the CD4+ T cells pool and is maintained at that level for males
and females. This indicates that IL-4 competent CD4+ T cells are highly regulated in the islets
during diabetogenesis. A novel finding of this study is the predictable composition of IL-4
competent CD4+ T cells, CD4+ T cells and CD8+ T cells in the islets as diabetogenesis
progresses and the linear relationship between these components. It will be of great interest to
know if treatments that cure diabetes in NOD mice and increase the percentage of IL-4
expressing T cells in the islets do so by decreasing the inflammation which results indirectly
in an increase in IL-4 competent CD4+ T cells.
Tregs are also capable of suppressing inflammation. Given the decreased incidence of T1D in
male NOD mice, one possibility was that males have higher levels of Treg. Contrary to these
expectations, young female NOD mice had higher levels of Tregs in their islets than their male
counterparts, although older female mice had slightly reduced levels of Tregs than their male
counterparts. On the other hand, in very old male NOD mice the percentage of Treg had dropped
substantially from the level of 12 week NOD males. When we examined the data on a
continuum, levels of Tregs were highest early in disease and decreased slowly as inflammation
continued to increase. These findings are in agreement with earlier work demonstrating that in
NOD female mice FoxP3+ CD4+ T cells in the PLN and islets decline with age, while the
FoxP3+ cells in the spleen do not 28,31. Again, changes in the frequency of FoxP3+ CD4+ T
cells may be a result of the level of islet inflammation and not the sex of the NOD mice.
IGRP-specific CD8+ T cells are diabetogenic and have been used to predict the onset of diabetes
45,46. Accordingly, we anticipated male NOD mice might not have IGRP-specific CD8+ T
cells. When grouped, female NOD mice did have much higher numbers of IGRP-specific
CD8+ T cells. However, the number of IGRP+ T cells per islet in 27 week-old male NOD mice
was comparable to that of the 12–14 week-old females. When we examined IGRP-specific T
cells as percentage of the islet CD8+ T cell pool, female mice were not significantly different
from male NOD mice. Next we examined the phenotype of the IGRP-specific CD8+ T cells
to see if they were antigen experienced. As expected, the IGRP-specific CD8+ T cells in the
islets of females were CD44hi CD62Llo effector cells, while those in the lymph nodes and
spleen were CD62Lhi memory or naïve cells. The same distribution was also seen in males.
Again, the only differences between the male and female populations of IGRP-specific
CD8+ T cells were attributable to the total number of infiltrating cells. Enee et. al. recently
reported similar results for male and female NOD mice expressing HLA-A2 as a trans gene,
demonstrating that HLA-A2 had no effect of the Kd-restricted IGRP responses 47. These
findings in males are similar to that reported here. Hence, there was no evidence of selective
recruitment of IGRP-specific CD8+ T cells in female NOD mice.
One important observation from this study is the presence of large numbers of naïve T cells in
the islets. It had been previously thought that T cells infiltrating the islets were largely if not
exclusively activated, diabetogenic effectors. We found a large number of both naïve CD4+
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and naïve CD8+ T cells. Thus the islets may correspond to the beginnings of “lymph node-
like” structures seen in the pancreas of mice with advanced disease. Apparently the cells
making up these lymphoid structures can sequester naïve T cells. We also observed a large
pool of B cells infiltrating the islets, in agreement with others 29. B cells are required for the
development of diabetes and have been shown to be required for epitope spreading 48. In
mucosal tissue it has also been demonstrated that lymphotoxin produced by B cells can drive
the formation of lymphoid structures 49. The present study indicates that large numbers of both
B cells and naïve T cells are present in the islets in an increasingly inflammatory environment.
The large population of naïve T cells may be involved in epitope spreading seen later where
new autoantigen are recognized, and priming does not occur in the draining lymph node, but
takes place in the lymphoid structures in the islets. Thus priming could occur in a more
inflammatory environment.
The differences within the islets of male and female and young and old NOD mice did not
appear to be discrete. Islet infiltrates in male NOD mice contained levels of CD8+ T cells, B
cells, Th2, Treg, and IGRP reactive T cells comparable to those found in females at any set
level of inflammation, as defined by the number of CD4+ T cells per islet. In addition, NOD
male and female mice both had large pools of naïve T cells and B cells in their islets. Our data
suggest that the processes are similar in male and female mice, but that the rates of progression
differ. Indeed NOD/LtJ males ultimately developed diabetes at a 70% incidence, though not
in the normally allotted 20 weeks 43. Our data also indicate diabetogenesis in the islets
progresses with predictable levels of some lymphocytes. If the number of islets and number of
CD4+ T cells harvested from the islets is known for an individual NOD mouse we offer
formulas to predict the number of CD8+ T cells, IL-4 competent CD4+ T cells, naïve CD8+ T
cells and naïve CD4+ T cells that are present.
In this manuscript we have focused on the immune system mediated aspects of diabetogenesis
and the differences between males and females. We were able to show similar immune cells
accumulating in islets, but at different rates. We argue that the differences between males and
females are not due to qualitative differences in the autoimmune response. We also indentified
large pools of apparently naïve CD4+ and CD8+ T cells, which in the presence of B cells in
the islets, could contribute to epitope spreading.
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Infiltrating T cells increase with age in a regulated fashion.
(A) The number of islet-infiltrating lymphocytes is higher in NOD females than males and
increases with age. The total number of CD3+ CD4+ T cells, CD3+ CD8+ T cells or CD19+ B
cells, as determined by flow cytometry (see supplementary Fig. 2a for gating scheme), was
divided by the total number of islets isolated from individual NOD mice. In both male and
female mice, the increase in infiltrating lymphocytes was significant (* p<0.05 and ** p<0.01
by Mann Whitney test).
(B) Islets contain a high percentage of B cells. CD4+ or CD8+ T cells and B cells were
represented as a percent of the total lymphocytes. T cells are gated on CD3+ cells. (A and B;
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6–8 week-old males N=10, 6–8 week-old females N=14, 12–14 week-old males N=22, 12–14
week-old females N=18, 25–29 week-old males N=6)
(C) There is a linear relationship between the number of CD4+ and CD8+ T cells per islet. The
number of CD8+ T cells per islet was plotted against the number of CD4+ T cells per islet (n
= 41, age 6 to 14 weeks). Data fit a straight line with a slope of 0.3107+/−0.0080 and a Y-
intercept of −0.7292+/−0.695, r2=0.9738. Y=0.3107X − 0.7292, where Y= the number of
CD8+ T cells per islet and X= the number of CD4+ T cells per islet. Females, 6–8 week, N=9,
12–14 week, N=10; males, 6–8 week, N=7, 12–14 week, N=15.
B cells per islet were plotted against the number of CD4+ T cells (n = 36). The data fit to a
straight line with a slope of 0.9426, r2 of 0.7212. Females, 6–8 week, N=8, 12–14 week, N=10;
males, 6–8 week, N=5, 12–14 week, N=13. Insets show expanded scale near origin.
(D) The ratio of CD4+:B cells varies more than the CD4+:CD8+ ratio. The ratio of CD4+:B
cells varies from 3.2 to 0.17, a factor of 18, while the CD4+:CD8+ ratio varies from 9.6 to 2.2,
a factor of 4.4. The data in C was recalculated to compare the CD8+:CD4+ T cell ratio and the
B cell:CD4+ T cell ratio with the level of inflammation as determined by the number of
CD4+ T cells/islet.
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The CD4+:CD8+ T cell ratio is maintained as insulitis progresses.
(A) Six diabetic female and six 25–29 week-old non-diabetic male NOD mice were plotted
with the 42 or 36 individual NOD mice from Fig. 1C. The lines from Fig. 1C were extended
to better allow comparison of the data.
(B) The data in A was recalculated to compare the ratio of CD8+ to CD4+ T cells or the ratio
of B cells to CD4+ T cells with the level of inflammation as determined by the number of
CD4+ T cells/islet.
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The number and percentage of IL-4 capable CD4+ T cells change with age.
(A) The percentage of CD4+CD3+GFP+ T cells in the CD4+CD3+ T cell population. Islets had
significantly more IL-4+ cells than other tissues in: 6–8 week males, p=0.006; 6–8 week
females, p<0.0001; and 12–14 week males, p<0.0001; 12–14 week females, p=0.009 (Mann
Whitney test). There was no significant difference in the percentage of IL-4+ cells in the islets
with age and sex (Kruskal Wallis test).
(B) Only a small fraction of CD4+ T cells are IL-4+ after insulitis reaches 50 CD4+ T cells/
islet. Inset show expanded scale near origin.
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(C) These 3 panels show all of the islet-infiltrating CD3+CD4+ T cells isolated from a 12 week-
old and two 6 week old female NOD-IL-4gfp mice. The total number of islets recovered from
each mouse is given. The percentage of cells in the gate is shown and the number of cells is in
parenthesis. See supplementary Fig. 2b for gating scheme.
(D) The fraction of IL-4 competent cells remains constant as insulitis increases (n = 26). The
data fit a straight line with a slope of 0.0308+/−0.001542 and an intercept of 0.107+/–0.1093.
R2=0.94 (6–8 week-old males N=5, 6–8 week-old females N=7, 12–14 week-old males N=10,
12–14 week-old females N=4). Inset show expanded scale near origin.
Raw data and calculations for the above graphs can be found in Supplemental data Table 2. A
discussion of the relationships between X:Y ratios and the slope and Y-intercepts of straight
lines can be found in Supplemental Fig. 3.
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The number of Treg increase with age. Treg were identified as CD4+CD3+FoxP3+ T cells.
(A) Dot plot shows the entire population of islet-infiltrating CD3+ T cells isolated from 148
islets recovered from one 12 week-old female NOD mouse. The percentage of cells in the gate
is shown and the number of cells is in parenthesis. See supplementary Fig. 2a for gating scheme.
(B) Treg are expressed at the highest frequency in the islets. (6–8 week-old males N=4, 6–8
week-old females N=5, 12–14 week-old males N=4, 12–14 week-old females N=4, 25–29
week-old males N=6)
(C) The average number of islet-infiltrating CD4+CD3+FoxP3+ T cells per islet increases with
age (black bars). The number of islet-infiltrating CD4+CD3+CD25hi T cells/islet is shown in
white bars.
(D) The percentage of FoxP3+ or CD25hi cells in the CD4+CD3+ T cells pool gradually
decreases with increasing insulitis (N = 29). In mice where CD25 was stained along side FoxP3,
the CD25hi population coincided well.
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IGRP-specific CD8+ T cells have an effector T cell phenotype in the islets
(A) The dot plots show the total islet-infiltrating CD3+CD8+ IGRP+ T cells isolated from 81
islets recovered from a 12 week-old female NOD mouse are antigen experienced. The
percentage of cells in the gate is shown and the number of cells is in parenthesis. See
supplementary Fig. 2b for gating scheme.
(B) Females have more IGRP-specific CD8+ T cells per islet than males of the same age but
the percentage is similar between sexes. Twelve to fourteen week-old NOD female mice had
significantly more IGRP-specific CD8+ T cells per islet than NOD males of the same age
(p=0.004). IGRP-specific CD8+ T cells were identified using PE conjugated NRP-V7-Kd
Young et al. Page 18













tetramers. To determine number of cells per islet, the total number of CD8+CD3+CD19− NRP-
V7+ cells was divided by the number of islets isolated from individual mice. Therefore a mouse
that had 100 IGRP+ T cells recovered from 100 islets would have 1 IGRP+ T cell per islet. An
average of more than 100 islets was isolated from each mouse.
(C) Percentage of CD8+CD3+CD19− NRP-V7+ cells in the CD8+CD3+CD19− population was
determined for spleen, inguinal lymph nodes, PLNs and islets. Islets had significantly more
IGRP+ cells than other tissues in 6–8 week males (p=0.041) 12–14 week males (p=0.030) and
12–14 week females (p=0.0001). Six to eight week-old females were not significantly different
(p=0.083) but this group contained two mice with no islet-infiltrating IGRP+ cells.
(D) IGRP-specific cells in the islets have an effector phenotype based on their expression of
CD62L and CD44 (panel A).
(B–D, 6–8 week-old males N=5, 6–8 week-old females N=7, 12–14 week-old males N=11,
12–14 week-old females N=8, 25–29 week-old males N=3)
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IGRP-specific CD8+T cells do not increase linearly with increasing inflammation but do make
up a substantial proportion of the effector CD8+ T cells pool.
(A) The number of CD8+CD3+CD19− NRP-V7+ cells per islet was plotted against the number
of total CD4+ T cells per islet for 34 mice.
(B) Percent IGRP-specific effector CD8+ T cells (number of CD62LloCD44hi
CD8+CD3+CD19− NRP-V7+ cells/number of CD62LloCD44hi CD8+CD3+CD19− cells x100)
is shown. Krushal-Wallis test indicated means were not significantly different, p=0.066.
(A and B, 6–8 week-old males N=5, 6–8 week-old females N=7, 12–14 week-old males N=11,
12–14 week-old females N=8, 27 week-old males N=3)
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Islets from older female NOD mice have a substantial number of naïve and effector T cells.
(A) Representative gates for naïve (CD62Lhi CD44lo), memory (CD62Lhi CD44hi) and effector
(CD62Llo CD44hi) T cells in 55 islets from a 12 week-old NOD female are shown. The
percentage of cells in each gate is shown and the number of cells in each gate in the islets is in
parenthesis.
(B and C) The percent of naïve CD4+ and CD8+ T cells in the islets increases with age while
in lymphoid tissues the percent of naive, memory or effector phenotypes does not change. Cells
were classified as in (A). There was a significant increase in naïve CD4+ T cells in the islets
(p < 0.01) but not in other tissues. Other subsets did not change. (6–8 week-old males N=10,
6–8 week-old females N=14, 12–14 week-old males N=24, 12–14 week-old females N=18)
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The number of naïve CD4+ and CD8+ T cells increases as insulitis increases. The number of
naïve CD4+ or CD8+ T cells per islet was plotted against the number of total CD4+ or CD8+
T cells per islet (n = 42, age 6 to 14 weeks). (A) Naive versus total number of CD4+ T cells.
Data fit a straight line with a slope of 0.3654+/−0.0104 and Y-intercept of −2.377+/−0.8384,
r2 = 0.9686. Y = 0.3654 X 2.377 (B) Naive versus total number of CD8+ T cells. Data fit a
straight line with a slope of 0.4023+/−0.0219 and Y-intercept of −0.1992+/−0.5453, r2 =
0.8937. Y = 0.4023 X − 0.1992 (6–8 week-old males N=7, 6–8 week-old females N=10, 12–
14 week-old males N=15, 12–14 week-old females N=10)
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Table 1
SNPs used to cross IL-4 reporter gene from BALB/c to NOD background
JAX SNP ID refSNP(rs) number With NCBI hyperlink New Chr pos (bp) Build 30
01-039504168-N rs4222284 39 421 714
01-100109616-M rs3695980 99 776 559
01-171257289-N rs4222821 170 722 671
02-038092910-M rs3709811 38 360 318
02-108953011-M rs3657882 109 547 910
02-164961358-M rs3697980 165 877 557
03-033933315-N rs4223883 33 920 148
03-124103177-M rs3720182 124 251 237
04-043070534-M rs3725792 43 076 423
04-115172853-M rs3696331 115 410 443
05-038394376-M rs3716546 38 096 627
05-116192311-M rs3661429 115 463 027
06-024909331-M rs3665582 24 860 970
06-109051116-M rs3715148 108 877 662
07-034063244-M rs3710949 33 124 503
07-109117173-M rs3670069 107 748 124
08-032986730-M rs3653751 32 953 469
08-101099186-M rs3726020 100 652 541
09-037841497-M rs3705980 37 624 235
09-100909970-M rs3658704 100 364 790
10-020086252-M rs3667084 19 915 360
10-100345477-M rs3710293 99 641 926
11-033040833-M rs3723833 33 409 549
11-077198334-M rs3658198 77 352 730
11-100359477-N rs4229088 100 422 259
12-030450532-M rs3669704 30 483 177
12-084289638-M rs3707414 84 101 707
13-030913320-M rs3654710 30 862 328
13-091042598-M rs3675592 90 070 327
14-020426806-M rs3682880 20 327 446
14-088110939-M rs3684516 87 899 822
15-020953071-M rs3714893 20 803 443
15-087100507-M rs3690689 86 587 928
16-015729768-C rs4165029 15 729 538
16-066862514-C rs4197416 66 800 359
17-023385048-N rs3023864 22 884 108
17-076128192-M rs3674930 75 497 960
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JAX SNP ID refSNP(rs) number With NCBI hyperlink New Chr pos (bp) Build 30
18-017475340-N rs3090636 17 597 947
18-080151519-M rs3656292 79 931 833
19-021081804-M rs3692864 20 719 054
19-060030696-N rs3023517 59 767 603
X-049771621-M rs3670652 50 829 113
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